Diploma (LON:DPLM - Get Free Report)'s stock had its "buy" rating restated by research analysts at Deutsche Bank Aktiengesellschaft in a report issued on Friday, MarketBeat.com reports. They currently have a GBX 5,100 ($63.93) price objective on the stock. Deutsche Bank Aktiengesellschaft's target price would indicate a potential upside of 14.20% from the stock's previous close.
Separately, Shore Capital lowered shares of Diploma to a "hold" rating in a research note on Tuesday.
Read Our Latest Analysis on DPLM
Diploma Stock Performance
LON DPLM traded up GBX 244 ($3.06) during trading hours on Friday, reaching GBX 4,466 ($55.99). The stock had a trading volume of 385,324 shares, compared to its average volume of 376,993. The stock has a market cap of £5.99 billion, a P/E ratio of 5,193.02, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. Diploma has a 52-week low of GBX 3,200 ($40.12) and a 52-week high of GBX 4,653 ($58.33). The stock has a fifty day moving average of GBX 4,384.27 and a 200 day moving average of GBX 4,270.44. The company has a debt-to-equity ratio of 45.69, a quick ratio of 0.80 and a current ratio of 2.27.
Insider Activity
In related news, insider Johnny Thomson sold 26,794 shares of the stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of GBX 4,536 ($56.86), for a total value of £1,215,375.84 ($1,523,600.15). Company insiders own 0.52% of the company's stock.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Recommended Stories
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
